Laura Shawver, Director at ARS Pharmaceuticals, Inc. (SPRY), sold 182,284 shares at $6.34 ($1.2M) on 2023-07-06, disclosed to the SEC on 2023-07-06.
Open-market sale of $1.2M SPRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.73 | 26,520 | $178K | 15.1% |
| 2 | $6.73 | 26,520 | $178K | 15.1% |
| 3 | $6.41 | 31,112 | $199K | 16.9% |
| 4 | $6.41 | 31,112 | $199K | 16.9% |
| 5 | $6.34 | 33,510 | $212K | 18.0% |
| 6 | $6.34 | 33,510 |
| $212K |
| 18.0% |
| Total | $6.48 avg | 182,284 | $1.2M | 100% |
| Filing → |
| SPRY | SELL | 2025-02-04 | $616K | — | Filing → |
| SPRY | SELL | 2025-01-07 | $555K | — | Filing → |
| SPRY | SELL | 2024-12-04 | $5.2M | — | Filing → |